KCNA3 and cancer: Among many inhibitors of Kv1.3 channels, the most promising candidates for a potential clinical application may be some small molecule organic compounds, since they combine a high efficiency and specificity of cancer cell elimination with a good bioavailability and a low cytotoxity (Leanza et al. 2012, 2013).